Skip to content
MedBiz Pro

e-mail: info@medbizpro.com
  • News
  • Blog Zone
  • Contact
  • sr
MedBiz Pro > Oglasi > Lokal u Obrenovcu, 300€

Lokal u Obrenovcu, 300€

Posted on 05/10/201805/10/2018 by Mila

Izdaje se lokal površine 40m2 u prizemlju poslovno stambene zgrade u centru Obrenovca, na par minuta hoda od glavne ulice i pošte. Lokal se sastoji od jedne velike prostorije, toaleta, ostave. Mesečni najam 300e+depozit.

Kontakt: 0628345873 , 0649101261,

Više informacija: http://www.nadjidom.com/sr/details/382179/Beograd-Obrenovac-Izdavanje-Lokal.html

Posted in Oglasi
Post navigation
Lokal Novi Sad, Novo Naselje, Bulevar, 150€ →
← Lokal u centru Kragujevca, 500€

News

  • Routine blood test may flag hidden osteoporosis risk, study finds
    on 09/12/2025 at 5:17 am

    A large hospital-based cross-sectional study examined whether routinely measured serum alkaline phosphatase can indicate osteoporosis risk in adults undergoing health checks. Higher ALP levels, even within the normal range, were associated with greater osteoporosis likelihood, particularly in younger, female, and metabolically healthy individuals.

  • Supportive marriages may shape appetite control through oxytocin and the brain–gut axis
    on 09/12/2025 at 4:34 am

    Supportive marital relationships are associated with lower BMI, fewer food addiction symptoms, higher oxytocin, stronger frontal brain responses to food cues, and favorable gut tryptophan metabolites. These coordinated social, neural, hormonal, and gut pathways suggest a plausible biological link between emotional support and healthier eating regulation.

  • Hotter days and nights are already stealing sleep across the U.S.
    on 09/12/2025 at 4:14 am

    Rising nighttime and daytime temperatures are associated with reduced sleep duration, poorer sleep continuity, delayed sleep onset, and altered sleep stages in a large U.S. cohort tracked with wearable devices. Vulnerability is greatest among adults aged 40–50 years, females, people with lower socioeconomic status, chronic conditions, and those living in marine climate zones, with climate change projected to further magnify sleep loss.

  • Everyday PFAS exposure alters placental function in early pregnancy
    on 09/12/2025 at 3:41 am

    This study measured real-life PFAS concentrations in first-trimester human placentas and used these data to create a pregnancy-relevant PFAS mixture. In 3D trophoblast spheroid models, the mixture altered invasion, hormone secretion, and gene expression without broadly reducing viability at environmentally relevant doses.

  • A 36-week screening strategy safely reduces pre-eclampsia at term
    on 09/12/2025 at 3:18 am

    Screening pregnant women at 36 weeks using a validated risk model and offering risk-stratified planned early-term birth reduced the incidence of term pre-eclampsia by about 30 percent without increasing maternal or neonatal complications. The randomised PREVENT-PE trial demonstrates that a personalised timing-of-birth strategy can prevent term pre-eclampsia where no effective medical prevention currently exists.

  • Early RSV infection turns maternal allergy into a powerful driver of childhood asthma
    on 09/12/2025 at 2:39 am

    Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by population data from more than 1.5 million children and mechanistic mouse experiments. The study shows that viral infection reprograms neonatal immune responses by altering how maternally transferred allergen-specific antibodies are handled, driving long-term allergic airway disease.

  • Laughing gas shows fast antidepressant effects in early clinical trials
    on 09/12/2025 at 2:21 am

    A systematic review and meta-analysis in eBioMedicine shows that nitrous oxide can rapidly reduce depressive symptoms within hours, particularly at higher doses, but effects are short-lived after single treatments. Repeated dosing appears to extend and strengthen antidepressant benefits, although the current evidence is based on small, early-phase trials with limited long-term safety data.

  • Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
    on 09/12/2025 at 2:04 am

    A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults fight a rare and aggressive form of blood cancer called T-cell acute lymphoblastic leukemia (T-ALL).

  • Powerful prognostic marker could enable early identification of high-risk cancer patients
    on 09/12/2025 at 1:53 am

    Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate.

  • Combination therapy may boost survival for people with aggressive lymphoma
    on 09/12/2025 at 1:44 am

    A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive lymphoma.

  • 2017 to 2023 Saw Decrease in Family Doctors Practicing in Rural Areas
    on 08/12/2025 at 8:11 pm

    MONDAY, Dec. 8, 2025 -- During 2017 to 2023, there was a year-over-year decrease in family physicians practicing in rural areas in the United States, according to a study published in the November/December issue of the Annals of Family...

  • Sex Toy Use Common Among Older Women
    on 08/12/2025 at 8:10 pm

    MONDAY, Dec. 8, 2025 -- Many older women use sex toys to promote orgasm, according to a study published online Nov. 25 in Menopause.Jessica J. Hille, Ph.D., from Indiana University in Bloomington, and colleagues conducted a national survey of 3,001...

  • 1 in 4 ACA enrollees could go uninsured if subsidies lapse: KFF
    by Emily Olsen on 08/12/2025 at 3:23 pm

    Nearly 60% of survey respondents said they wouldn’t be able to afford a $300 annual increase in healthcare costs without significantly disrupting their finances.

  • 'Coming Out' Linked to Increased Suicide Risk in Sexual Minority Youth
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 -- For sexual minority youth, identity disclosure is associated with an increased risk for suicide intention, plan, and attempt, according to a study published online Dec. 3 in Pediatrics. Samuel Mann, Ph.D., from RAND...

  • One Dose of HPV Vaccine Noninferior to Two Doses
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 -- One dose of bivalent or nonavalent human papillomavirus (HPV) vaccine is noninferior to two doses for protecting against HPV16 and HPV18 infection, according to a study published online Dec. 3 in the New England Journal of...

  • FDA Approves Itvisma for Spinal Muscular Atrophy
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 -- The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron...

  • 210,000 Portable Power Banks Sold on Amazon Recalled After Fire Reports
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 — A popular portable phone charger sold online has been recalled after reports that it can overheat and catch fire, federal officials said. The recall covers about 210,000 INIU-branded lithium-ion power banks sold on...

  • Two Deaths Linked to Rabies-Infected Kidney Transplant
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 — A rare case of rabies linked to an organ transplant has resulted in two deaths, federal health officials announced. The U.S. Centers for Disease Control and Prevention (CDC) reported that a man in Idaho became infected...

  • ASH: Guidelines Updated for Management of Acute Myeloid Leukemia in Older Adults
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 -- In updated 2025 American Society of Hematology guidelines, recommendations are presented for the management of newly diagnosed acute myeloid leukemia (AML) in older adults; the guidelines were published online Dec. 1 in Blood...

  • Timing of Immune Checkpoint Inhibitor Administration Affects Small Cell Lung Cancer Survival
    on 08/12/2025 at 3:12 pm

    MONDAY, Dec. 8, 2025 -- For patients with extensive-stage small cell lung cancer (ES-SCLC), administration of immune checkpoint inhibitor (ICI) therapy earlier in the day is associated with improved survival, according to a study published online...

Theme by Out the Box
  • News
  • Blog Zone
  • Contact